↓ Download Markdown  ·  GitHub source  ·  Context & question bank assessment →
Leave a comment on any question. This page has Hypothes.is annotations enabled — highlight any text and click the speech-bubble icon (or open the sidebar with the » tab at the top right) to post a note. Comments are public and visible to other readers. Sign up free if you don't have an account.

Common operationalization notes

Tournament context

These 7 questions are medium-to-long-term complements to the animal welfare forecasting tournament's existing question bank. Near-term questions — EU regulatory approval (2027), US state bans (2027), first commercial availability (2026–27) — are already well-represented in the broader bank. These questions fill three gaps: (1) meaningful market penetration at scale (Q1, Q1b), (2) product quality at commercial viability (Q2), and (3) unit economics at commercial scale (Q3–Q6). For analysis of how each question relates to existing proposals and a full explanation of the resolution dates, see the question bank assessment page.

Note on year choices: We are less confident about the specific resolution dates than we are about the question structures themselves. A natural refinement — standard on Metaculus — is to split each question into subquestions at multiple horizons (e.g. "by 2030 / by 2033 / by 2036"), allowing forecasters to express views across the timeline rather than committing to a single date. We welcome suggestions on which horizons are most decision-relevant for each question.

Questions in this document
Q1Cultivated chicken — ≥10% blend in mainstream retail (market penetration)
Q1bCultivated chicken blend — retail price ≤2× conventional (price parity)
Q2Cultivated chicken — blinded taste equivalence test (consumer acceptance)
Q3Average production cost of cultivated chicken in 2036 (numeric · core cost question)
Q4Precision fermentation egg white — price parity
Q5Cultivated shrimp (minced) — price-competitive availability
Q6Cultivated shrimp (whole tail) — commercially available
Q1 · Market penetration · Cultivated chicken

Will a commercial ground chicken product containing ≥10% cultivated chicken cells be available in mainstream retail in any G20 country by 2035?

Type: Yes / No Resolves: 31 Dec 2035 AW relevance: ~70 billion broilers/yr

Background

Cultivated chicken has received regulatory approval in Singapore (2020) and the United States (2023). Near-term commercial strategy for most companies involves blended products — combining conventional and cultivated chicken to reduce per-unit cost. A 10% cultivated fraction represents a commercially meaningful threshold: sufficient to begin displacing conventional production at the margins. This question tracks whether blended cultivated chicken crosses from pilot/restaurant sales into mainstream grocery retail. See Q1b for the companion price parity question.

Resolves YES if (before 31 Dec 2035)
  • A ground or minced chicken product available in ≥100 retail grocery outlets in any G20 country
  • Contains ≥10% cultivated chicken cells by raw/wet weight — stated on labeling, in company documentation, or confirmed by credible third-party analyst
  • Available for ≥3 consecutive months
Resolution sources
  • Product label + independent confirmation from: Food Navigator, Bloomberg Intelligence, SPINS/NielsenIQ, or academic publication
  • Regulatory approval documentation (USDA FSIS fsis.usda.gov, Singapore SFA, or equivalent) confirming cultivated content ≥10%
  • If labeling law does not require disclosure: third-party audit or investigative trade reporting
Fine print
  • Restaurant/food-service-only products do not qualify — must be retail
  • Blended products with cultivated fraction from a non-chicken species do not qualify
  • 10% threshold by raw wet weight (not protein weight or dry weight)
Context & provenance Operationalizes Row 1021 in the question bank ("blended meat options in X major restaurant chains by year Y"), moved from restaurants to retail and given a specific cultivated fraction threshold and G20 scope. The FURA Singapore near-term companion (Row 18, Feb 2027) is already in the broader bank. Resolution date (2035) set by judgment — no external anchor. See question bank assessment for full provenance.
Resolves: 31 December 2035
Q1b · Price parity · Cultivated chicken blend

Will a commercial ground chicken product containing ≥10% cultivated chicken cells be sold at ≤2× the retail price of equivalent conventional ground chicken in any G20 country by 2033?

Type: Yes / No Resolves: 31 Dec 2033 AW relevance: ~70 billion broilers/yr; companion to Q1

Background

Market penetration (Q1) and consumer acceptance (Q2) are necessary but not sufficient — price must also be competitive. A 2× price premium represents a plausible early commercial milestone for a novel product positioned on sustainability grounds. For context, organic ground chicken typically sells at 1.5–2.5× conventional; a cultivated-blend at comparable premium would be within consumer willingness-to-pay for sustainability attributes. This question asks whether the price gap has closed sufficiently for mainstream commercial viability within this decade.

Resolves YES if (before 31 Dec 2033)
  • A ground or minced chicken product meeting the ≥10% cultivated cell criteria (same as Q1) is commercially available in retail
  • Retail shelf price per kg is ≤2× the median retail price of comparable conventional ground chicken (same fat content, similar packaging size) in the same market
  • Price comparison verified from ≥3 retail outlets in the same metropolitan area, or from a published retail scanner database report
  • Price sustained for ≥4 consecutive weeks (not a temporary introductory promotion)
Resolution sources (all verified as publicly accessible)
  • USDA AMS Poultry Market News — free, weekly retail chicken prices in US cities: ams.usda.gov/market-news/poultry
  • BLS Consumer Price Index — free, monthly "fresh whole chicken" series (proxy): data.bls.gov
  • Eurostat food price statistics (EU markets): ec.europa.eu/eurostat
  • Retail scanner data (NielsenIQ, SPINS, Circana) — paywalled, but prices regularly cited in Food Navigator, Bloomberg, GFI State of the Industry
  • Direct retail documentation — screenshots of shelf prices from ≥3 major retailers + date stamp
Fine print
  • "Equivalent conventional ground chicken" = same form with comparable fat percentage (within 5pp); premium heritage breeds are not the benchmark
  • Price per kg adjusted for packaging — bulk/value packs converted to per-kg basis
  • If the cultivated blend is only sold in a premium section alongside premium conventional, the comparison uses the premium conventional price in that section
  • Temporary promotional pricing does not count — must be a sustained list price for ≥4 weeks
Context & provenance Related to — but more specific than — the question bank's grouped question: "Will cultivated meat reach price parity with conventional chicken by Dec 31, 2030?" That question lacks operationalization and asks about strict parity in any form. This question specifies a ≥10% blended product, a ≤2× threshold, retail channel, and 2033 resolution. Resolution date (2033) set by judgment — the spreadsheet's 2030 strict-parity question is the closest anchor but probes a different threshold and earlier milestone. See question bank assessment.
Resolves: 31 December 2033
Q2 · Consumer acceptance · Cultivated chicken

Will a commercially available cultivated or cultivated-blend ground chicken product pass a pre-registered blinded taste equivalence test by 2035?

Type: Yes / No Resolves: 31 Dec 2035 AW relevance: Prerequisite for mainstream adoption

Background

A cultivated chicken product must be indistinguishable from (or preferred over) conventional ground chicken to achieve mainstream uptake. While prototypes have been evaluated informally by chefs, rigorous third-party blinded equivalence testing on a commercial product has not yet been published. This question tracks when both production viability and consumer acceptance are independently validated for the same commercial product.

Resolves YES if (before 31 Dec 2035)
  • A peer-reviewed or pre-registered study is published on a commercially available ground chicken product containing ≥10% cultivated cells
  • ≥100 participants who self-identify as regular chicken consumers (≥2×/month)
  • Triangle test: ≤40% correctly identify the cultivated/blend as different (not significantly above 33% at p < 0.10) — OR — Preference test: ≥50% rate as "equivalent to or better than" conventional
  • Test conducted by a party independent of the manufacturer; cooking method standardized and described; product purchased through normal retail channels
Resolution sources
  • Peer-reviewed publication in food/sensory science journal: Food Quality and Preference, Journal of Sensory Studies, Appetite, Nature Food
  • Pre-registered study on OSF, AsPredicted, or ClinicalTrials.gov with published results
  • Third-party sensory analysis from credentialed firm (Mérieux NutriSciences, Intertek, SGS) with methodology publicly disclosed
Fine print
  • Company-internal taste surveys without third-party blinding do not qualify
  • Tests on laboratory prototypes do not qualify — must use the commercial product as sold
  • Failing triangle test but passing preference test resolves YES
Context & provenance Novel — no direct analog in the question bank. Consumer acceptance (taste quality) is entirely absent from the existing CM questions. Resolution date (2035) set by judgment, sequenced 2 years after Q1b (2033) to allow a commercial product to exist long enough for a taste study to be conducted on it.
Resolves: 31 December 2035
Q3 · Numeric · Core cost question · Cultivated chicken

What will be the average production cost ($/kg, factory-gate wet weight) of cultivated chicken cell biomass at large-scale commercial plants globally, as of December 2036? [2025 USD]

Type: Numeric ($/kg) Resolves: 31 Dec 2036 See also: CM_01 on Metaculus →

Background

The fundamental cost question for cultivated chicken is whether production costs will fall sufficiently to enable price-competitive products. This question operationalizes the central metric tracked in published techno-economic analyses (TEAs): the all-in manufacturing cost per kg of cultivated chicken cell biomass (wet weight, at harvest) at commercial scale.

Definitions: "Large-scale" = ≥10,000 L bioreactor working volume, or ≥100 tonnes annual output. "Factory-gate wet weight" = cost at point cells are separated from spent media, before downstream processing. "Average" = capacity-weighted average across operating commercial plants. Includes: media, growth factors, bioreactor capital (annualized), plant overhead, utilities. Excludes: texturization, blending, packaging, distribution.

This matches the definition used in Humbird (2021), Pasitka et al. (2024), and the Unjournal's CM_01 Metaculus question.

Resolution approaches — choose one at question creation

Option A — LLM synthesis (preferred; Metaculus-compatibility uncertain as of 2025)

At resolution date, a designated moderator queries a specified frontier AI model (version frozen at question creation) with all available public evidence and the following standardized prompt:

"Based on all publicly available evidence, what is your best estimate of the capacity-weighted average production cost per kg (wet weight, factory gate) of cultivated chicken cell biomass at commercial-scale plants (≥10,000 L bioreactor capacity) globally, as of December 2036, in 2025 USD? Provide: (1) a point estimate, (2) a 90% confidence interval, (3) your primary sources ranked by weight, (4) key assumptions. If no plants at this scale exist, provide the best near-commercial estimate and state the scale."

The AI's point estimate is the resolution value. If the 90% CI is wider than $50/kg, the question resolves ambiguous.

Why preferred: robust to GFI discontinuity; synthesizes multiple imperfect sources; handles the "no large-scale plants exist" edge case gracefully. As of 2025, Metaculus has not formally accepted this format — this is an evolving area.

Option B — GFI State of the Industry (Metaculus-compatible fallback)

Resolves to the median production cost estimate for commercial-scale cultivated chicken cited in the most recent GFI State of the Industry — Cultivated Meat, Seafood and Ingredients annual report published before December 31, 2036 (gfi.org). If GFI cites a range, the midpoint is used. Costs converted to 2025 USD using US CPI.

Risk: GFI may not exist in 2036, or may not publish a suitable cost figure. Fallback to Option C if unavailable.

Option C — Academic TEA median (secondary fallback)

Resolves to the median production cost estimate across peer-reviewed TEA papers for commercial-scale cultivated chicken published 2034–2036. Search: Google Scholar "cultivated chicken production cost" OR "cultured meat techno-economic" filtered to 2034–2036.

Resolution sources (verified as publicly accessible)
Fine print
  • If no large-scale plants exist by December 2036, the question resolves to the best available near-commercial estimate from the most advanced pilot facility, with an explicit note about the scale
  • Costs reported in non-USD currencies converted using 12-month average exchange rate preceding December 2036
  • If Option A produces a value outside the range [$1, $500/kg], the resolution is flagged for moderator review
  • "Per edible kg" (the phrasing in the source question bank, Row 1027) differs from "factory-gate wet weight" used here. Factory-gate wet weight is the pre-processing TEA convention used in Humbird (2021) and CM_01. We use this more precise definition; the per-edible-kg cost is higher because it includes downstream conversion losses.
Context & provenance Directly operationalizes Row 1027 of the question bank ("What will be the average production cost (per edible kg) of cultured chicken meat in the given years?") — marked TRUE (sufficiently finalised) but with no resolution criteria, no date, and no source. Resolution date (December 2036) is the only externally-anchored date in our set: it matches the Unjournal's CM_01 Metaculus question. See question bank assessment for full discussion.
Resolves: 31 December 2036
Q4 · Price parity · Precision fermentation

Will precision fermentation-derived egg white protein (ovalbumin, ≥80% protein) be commercially available at ≤120% of the conventional dried egg white commodity price, in quantities ≥1 tonne, by 2033?

Type: Yes / No Resolves: 31 Dec 2033 AW relevance: Layer hens + ~7 billion male chicks culled/yr

Background

Ovalbumin — the dominant protein in egg whites — has been produced via precision fermentation by companies including Every Company (formerly Clara Foods). Replacing conventional egg whites at scale would reduce demand for egg production and eliminate the routine culling of ~7 billion male chicks annually. The "120% threshold" reflects the typical early-market premium for novel food ingredients.

Resolves YES if (before 31 Dec 2033)
  • ≥1 company offers food-grade PF-derived ovalbumin (≥80% protein, spray-dried or equivalent) for commercial purchase by food manufacturers in quantities ≥1 tonne per order
  • List price for ≥1 tonne orders is ≤120% of the USDA AMS Egg Products Report price for spray-dried conventional egg white, averaged over the preceding 12 months
Resolution sources
  • USDA AMS Egg Products Report — free, quarterly, confirmed to report spray-dried egg white prices: ams.usda.gov/market-news/egg-products
  • Company price sheets corroborated by ≥1 independent source (distributor catalog, Food Navigator, Bloomberg Intelligence, or trade press)
  • If not publicly listed, wholesale quotes received by ≥3 independent food manufacturers
Fine print
  • Products sold only for pharmaceutical/cosmetic applications at pharma-grade prices do not qualify
  • 12-month rolling average used for the USDA benchmark to smooth short-term volatility
Context & provenance Implements the per-ingredient approach recommended by David Reinstein for Row 1023 of the question bank ("Which precision fermentation / cultivated food ingredients will reach price parity by year X?" — marked FALSE with note: "you'd need 1 question per ingredient"). Ovalbumin was chosen as the first ingredient because it has the clearest conventional analog and a publicly available benchmark price (USDA AMS). Resolution date (2033) set by judgment; PF is more technically mature than cultivated meat, justifying an earlier milestone than Q3. See question bank assessment.
Resolves: 31 December 2033
Q5 · Price parity · Cultivated shrimp (minced)

Will commercially available cultivated shrimp in minced or processed form (≥50% cultivated cells by weight) be sold at ≤2× the wholesale price of equivalent conventional processed shrimp by 2033?

Type: Yes / No Resolves: 31 Dec 2033 AW relevance: Hundreds of billions of shrimp/yr; de-eyestalling routine

Background

Near-term achievable cultivated shrimp will be minced/processed forms — suitable for dumplings, shrimp balls, shrimp paste — rather than whole-tail presentations (see Q6). Shrimp aquaculture involves hundreds of billions of animals in high-density conditions with routine practices including de-eyestalling of female broodstock.

Resolves YES if (before 31 Dec 2033)
  • A product containing ≥50% cultivated shrimp cells by raw wet weight (cells from Penaeus or equivalent edible shrimp species, grown in bioreactors) is available in minced, processed, or paste form
  • Available for regular commercial purchase in ≥1 country for ≥3 consecutive months
  • List price for ≥100 kg bulk orders is ≤2× the FOB benchmark for equivalent-grade conventional minced shrimp averaged over the preceding 12 months
Resolution sources
  • FAO FishStat — free, annual, shrimp production and trade price data: fao.org/fishery/statistics/software/fishstat
  • USDA NASS Aquaculture Survey — free, annual: nass.usda.gov
  • URNER BARRY (subscription) widely cited in Seafood Source, IntraFish, Undercurrent News — trade press quotations from these services are acceptable
  • Regulatory approval documentation (Singapore SFA, US FDA/USDA, EU EFSA) confirming cultivated content
Fine print
  • One-off restaurant promotions without a standard commercial price list do not qualify
  • Cultivated fraction must be ≥50%; blends below this threshold do not qualify
  • Price comparison uses bulk food-service pricing, not single-serve retail premium
Context & provenance Novel — no direct analog in the question bank. The shrimp welfare question in the bank (Row 8, TRUE) concerns corporate welfare commitments by EU retailers for conventional shrimp farming; our Q5/Q6 address replacement through cultivated seafood. Resolution date (2033) and the ≤2× threshold set by judgment. See question bank assessment.
Resolves: 31 December 2033
Q6 · Price parity · Cultivated shrimp (whole tail)

Will a commercially available whole-muscle cultivated shrimp tail (discrete tail morphology, ≥80% cultivated cells, no conventional shrimp casing) be sold at ≤3× the wholesale price of equivalent-size farmed shrimp in any market by 2038?

Type: Yes / No Resolves: 31 Dec 2038 AW relevance: Complete elimination of live shrimp farming for the product

Background

Whole-tail shrimp requires organized muscle fiber structure, which demands scaffolding or advanced biofabrication. The characteristic shrimp "snap" comes from highly aligned myofibril bundles and the chitin exoskeleton — both difficult to replicate in culture. This is the harder milestone, set with a 3× price threshold and later resolution date.

Resolves YES if (before 31 Dec 2038)
  • Discrete pieces with shrimp-tail morphology (elongated, segmented, visually recognizable as a shrimp tail) containing ≥80% cultivated crustacean cells
  • Does NOT use a conventional shrimp exoskeleton as an external casing (food-grade synthetic coating is acceptable)
  • Available for regular commercial purchase in ≥1 country for ≥3 consecutive months
  • List price for ≥10 kg bulk orders is ≤3× the FOB benchmark for equivalent-size conventional farmed shrimp (headless shell-on P. vannamei, 16/20 count/lb)
Resolution sources
  • Same as Q5 (FAO FishStat, URNER BARRY via trade press, regulatory disclosure)
  • Specific benchmark: headless shell-on P. vannamei, 16/20 count/lb (~22–28g per piece), FOB major producing countries
  • Verification that product contains ≥80% cultivated cells must come from a source independent of the manufacturer
Fine print
  • Products where a conventional shrimp shell is filled with cultivated mass do not qualify — must be a freestanding cultivated piece
  • Plant-based shrimp substitutes are excluded even if they incorporate cultivated cells
  • ≥3 months of consistent availability required — not a limited event launch
  • Independent verification of cultivated cell fraction (≥80%) required — manufacturer self-report alone is insufficient
Context & provenance Novel — no direct analog in the question bank. Whole-tail morphology requires scaffolding advances not expected before ~2033–2035, motivating the longer 2038 horizon. The 3× threshold (vs. 2× for Q5) reflects the harder technical challenge. Resolution date (2038) set by judgment. See question bank assessment.
Resolves: 31 December 2038

Notes on resolution approach for long-horizon questions

The GFI dependency problem: questions resolving in 2033–2038 may depend on GFI or similar organizations continuing to publish structured cost data. GFI has published annual reports since ~2018, but 10+ year continuity is uncertain.

LLM-based resolution (Option A for Q3): using a frontier AI model to synthesize available evidence at resolution date is more robust to institutional discontinuity than relying on a single source. As of 2025, Metaculus has not formally accepted this format, but this is an evolving area.

Fallback hierarchy for all questions: (1) primary named source, (2) equivalent industry body report, (3) academic literature median, (4) Metaculus community median at resolution date.